{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:48:50Z","timestamp":1792622930243,"version":"4.5.0"},"reference-count":20,"publisher":"Baishideng Publishing Group Inc.","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Cases"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>Vitamin deficiencies are linked to various eye diseases, and the influence of vitamin D on cataract formation has been noted in prior research. However, detailed investigations into the causal relationship between 25-(OH)D status and cataract development remain scarce.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To explore a possible causal link between cataracts and vitamin D.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>In this study, we explored the causal link between 25-(OH)D levels and cataract development using Mendelian randomization. Our analytical approach included inverse-variance weighting (IVW), MR-Egger, weighted median, simple mode, and weighted mode methods. The primary analyses utilized IVW with random effects, supplemented by sensitivity and heterogeneity tests using both IVW and MR-Egger. MR-Egger was also applied for pleiotropy testing. Additionally, a leave-one-out analysis helped identify potentially impactful single-nucleotide polymorphisms.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>The analysis revealed a positive association between 25-(OH)D levels and the risk of developing cataracts (OR = 1.11, 95%CI: 1.00-1.22; P  = 0.032). The heterogeneity test revealed that our IVW analysis exhibited minimal heterogeneity (P  &gt; 0.05), and the pleiotropy test findings confirmed the absence of pleiotropy within our IVW analysis (P  &gt; 0.05). Furthermore, a search of the human genotype-phenotype association database failed to identify any potentially relevant risk-factor single nucleotide polymorphisms.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>There is a potential causal link between 25-(OH)D levels and the development of cataracts, suggesting that greater 25-(OH)D levels may be a contributing risk factor for cataract formation. Further experimental research is required to confirm these findings.<\/jats:p>","DOI":"10.12998\/wjcc.v12.i16.2789","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:55:01Z","timestamp":1716879301000},"page":"2789-2795","source":"Crossref","is-referenced-by-count":3,"title":["Causal association between 25-hydroxyvitamin D status and cataract development: A two-sample Mendelian randomization study"],"prefix":"10.12998","volume":"12","author":[{"given":"Chun-Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Kun","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"B1","unstructured":"Who Health Organization.   Blindness and vision impairment. Aug 10, 2023. [cited 25 February 2024]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17201"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300539"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1987.82"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(05)80110-9"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(01)00626-1"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.09.046"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00126"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2035"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq398"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1706-3"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi118"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.938356"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22357"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.11.002"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathophys.2006.05.006"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2017.1281427"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-16835"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2014.12.052"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.09.015"}],"container-title":["World Journal of Clinical Cases"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i16\/2789.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i16\/2789.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:56:05Z","timestamp":1716879365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2307-8960\/full\/v12\/i16\/2789.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":20,"journal-issue":{"issue":"16"},"URL":"https:\/\/doi.org\/10.12998\/wjcc.v12.i16.2789","relation":{},"ISSN":["2307-8960"],"issn-type":[{"value":"2307-8960","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,6]]}}}